Corporate members (11) |
Databases and bioinformatics tools (6) |
Good practice guidelines (17) |
Organisations (11) |
Corporate members
- Beijing Yiling Institute of Pharmaceutical R&D Co. Ltd.
- Capital Medical University
- Chang Gung Memorial Hospital, Taiwan
- Chengdu University of TCM
- China Medical University, Taiwan
- CMC Tasly Group BV, Amsterdam, The Netherlands
- Guangdong Provincial Hospital of Chinese Medicine, China
- PuraPharm
- Shanghai University of TCM
- Taiji Group
- Tianjin University of TCM
Databases and bioinformatics tools
- Phytochemical Databases of Chinese Herbal Constituents & Bioactive Plant Compounds with Known Target Specificities
TCM Database paper - research from King's College London - Phytochemical Informatics of Traditional Chinese Medicine & Therapeutic Relevance
Chemiformatics paper - research from King's College London - TCM-ID Database (Singapore)
TCM-ID Database (Singapore) - TCMGeneDIT Database (Taiwan)
TCMGeneDIT Database (Taiwan) - Virtual Screening of Chinese Herbs with Random Forest
Chemiformatics paper - research from King's College London - Web-based TCM Information database
Traditional Chinese Medicine Information Database
Good practice guidelines
According to the GP-TCM RA bylaws, the Association is dedicated to promoting high-quality evidence-based research of traditional Chinese medicine (TCM) through developing, disseminating and implementing good practice.
This section of the website puts together good practice guidelines developed by the FP7 GP-TCM consortium and other international organisations for easy access by GP-TCM RA members.
Of an additional note, displaying these guidelines here should not be taken as an evidence that the Association endorse these guidelines, however, we do hope that these guidelines are helpful and important references to our members and serve as good starting points for further development, dissemination and refinement of good practices across all areas of TCM research.
- CIMR: Core Information for Metabolomics Reporting
including a list of publications on technical details of metabolomics and chemical analysis - European Charter for Researchers
- GP-TCM Checklist for Consistent and Acceptable Quality of Herbal Research Materials
- GP-TCM Definition to Good Practice in TCM Research
- GP-TCM Good Practice Guidelines on Reviewing and Publishing Studies on Herbal Medicine, with Special Emphasis on Traditional Chinese Medicine and Chinese Materia Medica
- GP-TCM Guidelines for Randomized Controlled Trials Investigating Chinese Herbal Medicine (CHM) - Summary
- GP-TCM Guidelines for Randomized Controlled Trials Investigating Chinese Herbal Medicine (CHM) and a Summary to This Guideline
- GP-TCM Position on Good Practice in TCM Research
- MIAME: Minimum Information About a Microarray Experiment
- MIAPapAE: Minimum Information About a Peptide Array Experiment
Please also visit: http://journal.embnet.org/index.php/embnetjournal/article/view/250/715 - MIAPE: Minimum Information About a Proteomics Experiment
including a 'parent' document laying out principles and a number of 'modules' (MS, MSI & GE, etc) each of which applies to a particular technology - MIARE: Minimum Information About a RNAi Experiment
- MIBBI Bioscience Reporting Guidelines and Tools
Some MIBBI guidelines of particular interest (MIQE, CIMR, MIAME, MIAPE, MIAPapAE and MIARE) are listed independently below. For a full range of MIBBI guidelines and tools, please visit - MIQE: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- The European Agency for Safety and Health at Work Guidelines
- The Quest for Modernisation of TCM
- Wellcome Trust Guidelines on Good Research Practice
Organisations
- British Pharmacological Society
- CAMbrella consortium
EC - FP7 funded Coordination Action Project for complementary and alternative medicine - Consortium for Globalisation of Chinese Medicine (CGCM)
- European Medicines Agency (EMA)
- International Society of Chinese Medicine
- International Society of Ethnopharmacology
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Society for Medicinal Plant and Natural Product Research
- State Food and Drug Administration, P. R. China (SFDA)
- The International Society of Regulatory Toxicology & Pharmacology
- U.S. Food and Drug Administration (FDA)
Print 
PDF